Skip to main content
OpenTrials
Completed

NCT Number: NCT03653598

BLITZ Atrial Fibrillation

Management strategies for AF have made many advances over the last decade but there is still a great heterogeneity in the management of AF and it remains unclear how often clinicians adhere to current guidelines.

A survey of an updated AF management would enable a timely assessment of implementation of current International guidelines, allow monitoring of early management of AF when a patients is admitted in a Emergency Room (ER) and Cardiology Unit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ospedale San Giovanni Di Dio - Uo Cardiologia E Utic, Agrigento, AG, Italy

Loading trial locations.

About this study

Multicentre, observational study. 200 Italian Hospitals fully representing the Italian cardiology reality in terms of geographical distribution and level of hospital technology.

Data collection in ER: Data on AF and Atrial Flutter episodes in ER will be collected retrospectively by checking the records of ER without collection of any data that can allow to identify the patients. These data will be collected under the responsibility of the Cardiology Departments consecutively for 4 weeks.

Data collected in Cardiology: these data will be collected under the responsibility of the Cardiology Departments for 12 weeks consecutively.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with AF, admitted to cardiology wards for an urgent or planned hospitalization.
  • All patients admitted in a Day Hospital regimen for treatment of AF The diagnosis of AF must be confirmed by ECG.
  • Signed Patient Inform Consent.

Exclusion criteria

  • The qualifying episode of AF was not documented with an ECG.
  • Age <18 years.
  • Patients with AF as a complication of an acute coronary syndrome (within 1 week from symptoms onset).
  • Patients with AF associated with cardiothoracic surgery (within 1 week from surgery).
  • Concomitant participation in other studies that can modify the diagnostic and/or therapeutic treatments.
  • Patients already enrolled in BLITZ-AF

Treatment and study plan

Atrial fibrillation

Other

Data collection on Atrial Fibrillation

Primary outcomes

  1. Number of admissions of patients with AF

    Time frame: Enrollemnt

    Number of admissions to the ER and cardiology wards of patients with AF

  2. Rate or rhythm control strategy

    Time frame: Baselane study completion - average 1 week

    Percentage of patients in rate or thythm control therapy

  3. Antithrombotic strategies

    Time frame: Baselane study completion - average 1 week

    Rate of use of oral antithrombotic strategies

Secondary outcomes

  1. Admission to the ER for atrial flutter

    Time frame: Enrollment

    Number of admission to the ER for atrial flutter

  2. Patients regularly followed up by the cardiology centers

    Time frame: 12 months

    Rate of patients regularly followed up by the cardiology centers

  3. Adherence to the 1A recommendations of current guidelines

    Time frame: 12 months

    Rate of adherence to the 1A recommendations of current guidelines

Sponsors and collaborators

Lead sponsor

Heart Care Foundation

Other

Registry information

Acronym: BLITZ-AF

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Aug 31, 2018
Registry last updated
Sep 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.